证据表明阿尔茨海默氏症是竞争性突触可塑性的疾病已经失败了
1Departments of Neuroscience and Neurology, University of Wisconsin-Madison, Madison, WI, USA.
Journal of Alzheimer's disease : JAD
|April 26, 2024
概括
粉样蛋白-β (Aβ) 调节大脑突触竞争,与阿尔茨海默病 (AD) 相关的干扰. 质 ApoE 和 Aβ 寡合体相互作用以管理突触消除,睡眠在这种可塑性中起着至关重要的作用.
科学领域:
- 神经科学是一个神经科学.
- 突触性可塑性 突触性可塑性
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 粉样β (Aβ) 越来越多地被认为是其在神经活动依赖的突触可塑性中的生理作用.
- 在调解细胞和突触竞争方面,Aβ与抗微生物共享机制.
- 这些机制的失调与阿尔茨海默病 (AD) 的病理生理学有关.
研究的目的:
- 审查最近关于Aβ介导突触竞争及其与AD的联系的证据.
- 探索Aβ和Apolipoprotein E (ApoE) 在调节突触竞争中的合作作用.
- 突出睡眠在Aβ编排的突触可塑性中的作用及其与AD的联系.
主要方法:
- 关于Aβ,ApoE和突触可塑性的最新研究的综述.
- 对细胞/突触竞争背后的机制的分析.
- 检查Aβ,ApoE,神经元功能和睡眠之间的相互作用.
主要成果:
- Aβ和ApoE在突触竞争中合作:Glial ApoE通过调节Aβ单体的产生和寡合化来支持自我保护,而Aβ寡合物则消除了竞争对手的突触.
- 神经ApoE可能参与一种促进竞争性可塑性的基因调节网络,这可能解释了AD的选择性脆弱性.
- 睡眠对于Aβ介导的可塑性至关重要,因为它既是这些过程所诱导的,也是这些过程所要求的,将睡眠障碍与AD联系起来.
结论:
- 阿尔茨海默病可以被视为异常竞争性突触可塑性的疾病.
- 了解Aβ和ApoE在突触竞争中的相互作用为AD研究提供了新的视角.
- Aβ,突触可塑性和睡眠之间的复杂关系对大脑健康至关重要,需要进一步研究.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在 ApoEEE 中.修复DNA损伤的修复粉样化物-β-β 的存在.树突性脊柱 树突性脊柱 树突性脊柱恒温的可塑性 恒温的可塑性mGluR5R5 在线观看酸盐酸氨酸的含量是多少睡眠 睡眠 睡眠 睡眠 睡眠突触性竞争 突触性竞争是指突触性竞争.更多相关视频
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.1K
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
6.2K
相关概念视频
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Long-term Potentiation
2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.8K
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Neuroplasticity
338
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
338
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
